UPDATE 1-Novartis says radioligand therapy improves prostate cancer survival

mr bill

Veteran Member

Joined : Sep 2010

Posts : 941

Posted 3/23/2021 6:57 PM (GMT 0)

ZURICH (Reuters) - Novartis’ experimental Lu-PSMA-617 radioligand therapy has improved the survival of prostate cancer patients with a hard-to-treat form of the disease, the Swiss drugmaker said on Tuesday.

https://www.reuters.com/article/novartis-radiogland-therapy/update-1-novartis-says-radioligand-therapy-improves-prostate-cancer-survival-idusl8n2ll5wv

Sr Sailor

Veteran Member

Joined : Sep 2015

Posts : 1483

Posted 3/24/2021 3:20 PM (GMT 0)

Beware:
No data whatsoever in that press release.
Will need to wait until presented at a forthcoming meeting and then we will have to wait some more for a peer-reviewed paper. Nevertheless, I am hopeful.

mattam

Veteran Member

Joined : Aug 2015

Posts : 4323

Posted 3/24/2021 3:23 PM (GMT 0)

Results may not be revealed until ASCO meeting in June.

Cyclone-ISU

Veteran Member

Joined : Oct 2014

Posts : 3388

Posted 3/24/2021 9:39 PM (GMT 0)

Sounds hopeful and promising ... we'll await that anticipated data release from the clinical studies.

It would be GREAT to add another new weapon to the armory!

Thankful to the researchers who are digging deeper into the challenging research it takes to treat complex and advanced cases.

I feel a debt of gratitude to every fellow who participated in the clinical trials, along the way ... and may I find a way to pay it forward.

Thankful for this update, Mr. Bill !

Here's to new horizons on the treatment landscape!

CYCLONE ~~~ # Iowa State University

Sr Sailor

Veteran Member

Joined : Sep 2015

Posts : 1483

Posted 3/24/2021 11:19 PM (GMT 0)

1. alephnull also brought this topic to our attention (at almost the same time);
https://www.healingwell.com/community/default.aspx?f=35&m=4242461

2. This kind of therapy has been available in several countries (Germany, Australia and India).

✚ New Topic ✚ Reply